Radiation and its Uses in the Treatment of Urologic Neoplasms

Radiology ◽  
1929 ◽  
Vol 13 (2) ◽  
pp. 109-114
Author(s):  
Charles A. Waters
Keyword(s):  
Urologic Neoplasms

IL-10 Polymorphisms and Urologic Neoplasms Risk: A Meta-Analysis

2015 ◽  
Vol 2 ◽  
pp. 121-129
Author(s):  
Kai-Ping Zhang ◽  
Xian-Guo Chen ◽  
Li Zhang ◽  
Cheng Yang ◽  
Chao-Zhao Liang
Keyword(s):  
Meta Analysis ◽  
Urologic Neoplasms

Bile duct carcinoma following abdominal radiation for urologic neoplasms

1994 ◽  
Vol 1 (3) ◽  
pp. 285-288
Author(s):  
G. Froeschle ◽  
U. Meyer-Pannwitt ◽  
R. Schwarz ◽  
C. Werner ◽  
B. Kremer
Keyword(s):  
Bile Duct ◽  
Bile Duct Carcinoma ◽  
Duct Carcinoma ◽  
Urologic Neoplasms

Application of Conditionally Replicating Herpes Vector for Gene Therapy Treatment of Urologic Neoplasms

2000 ◽  
Vol 4 (2) ◽  
pp. 83-87 ◽  
Author(s):  
Masafumi Oyama ◽  
Takahito Yazaki ◽  
Takashi Ohigashi ◽  
Michio Hoshi ◽  
Yutaka Horiguchi ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Urologic Neoplasms ◽  
Therapy Treatment

Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival

2013 ◽  
Vol 32 (2) ◽  
pp. 475-479 ◽  
Author(s):  
Vincent Bourgade ◽  
Sarah J. Drouin ◽  
David R. Yates ◽  
Jerôme Parra ◽  
Marc-Olivier Bitker ◽  
...  
Keyword(s):  
Surgical Removal ◽  
Urologic Neoplasms

scholarly journals Updates in Histologic Grading of Urologic Neoplasms

2020 ◽  
Vol 144 (3) ◽  
pp. 335-343 ◽  
Author(s):  
Travis Rice-Stitt ◽  
Aida Valencia-Guerrero ◽  
Kristine M. Cornejo ◽  
Chin-Lee Wu
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Bladder Neoplasms ◽  
World Health ◽  
Routine Practice ◽  
Ongoing Research ◽  
Histologic Grading ◽  
Tumor Histology ◽  
Urologic Neoplasms

Context.— Tumor histology offers a composite view of the genetic, epigenetic, proteomic, and microenvironmental determinants of tumor biology. As a marker of tumor histology, histologic grading has persisted as a highly relevant factor in risk stratification and management of urologic neoplasms (ie, renal cell carcinoma, prostatic adenocarcinoma, and urothelial carcinoma). Ongoing research and consensus meetings have attempted to improve the accuracy, consistency, and biologic relevance of histologic grading, as well as provide guidance for many challenging scenarios. Objective.— To review the most recent updates to the grading system of urologic neoplasms, including those in the 2016 4th edition of the World Health Organization (WHO) Bluebook, with emphasis on issues encountered in routine practice. Data Sources.— Peer-reviewed publications and the 4th edition of the WHO Bluebook on the pathology and genetics of the urinary system and male genital organs. Conclusions.— This article summarizes the recently updated grading schemes for renal cell carcinoma, prostate adenocarcinomas, and bladder neoplasms of the genitourinary tract.

Urinary Lactic Acid Dehydrogenase Activity in the Diagnosis of Urologic Neoplasms

1966 ◽  
Vol 95 (1) ◽  
pp. 77-78 ◽  
Author(s):  
David A. Lee ◽  
Abraham T.K. Cockett ◽  
Barry M. Caplan ◽  
Neil Chiamori
Keyword(s):  
Lactic Acid ◽  
Dehydrogenase Activity ◽  
Lactic Acid Dehydrogenase ◽  
Acid Dehydrogenase ◽  
Urologic Neoplasms

scholarly journals The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update

Biomolecules ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1214
Author(s):  
Roberto Campagna ◽  
Valentina Pozzi ◽  
Graziana Spinelli ◽  
Davide Sartini ◽  
Giulio Milanese ◽  
...  
Keyword(s):  
Cancer Progression ◽  
Promote Cell Proliferation ◽  
Non Invasive ◽  
Urologic Neoplasms ◽  
Diagnosis And Prognosis ◽  
Urological Cancers ◽  
Solid Malignancies ◽  
Potential Biomarker ◽  
Wide Range ◽  
Prostate Cancers

Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation reaction of nicotinamide, using S-adenosyl-L-methionine as the methyl donor. Enzyme overexpression has been described in many non-neoplastic diseases, as well as in a wide range of solid malignancies. This review aims to report and discuss evidence available in scientific literature, dealing with NNMT expression and the potential involvement in main urologic neoplasms, namely, renal, bladder and prostate cancers. Data illustrated in the cited studies clearly demonstrated NNMT upregulation (pathological vs. normal tissue) in association with these aforementioned tumors. In addition to this, enzyme levels were also found to correlate with key prognostic parameters and patient survival. Interestingly, NNMT overexpression also emerged in peripheral body fluids, such as blood and urine, thus leading to candidate the enzyme as promising biomarker for the early and non-invasive detection of these cancers. Examined results undoubtedly showed NNMT as having the capacity to promote cell proliferation, migration and invasiveness, as well as its potential participation in fundamental events highlighting cancer progression, metastasis and resistance to chemo- and radiotherapy. In the light of this evidence, it is reasonable to attribute to NNMT a promising role as a potential biomarker for the diagnosis and prognosis of urologic neoplasms, as well as a molecular target for effective anti-cancer treatment.

Sign in / Sign up

Export Citation Format

Share Document